As of 2025-05-16, the Intrinsic Value of NOXXON Pharma NV (ALNOX.PA) is -1.61 EUR. This ALNOX.PA valuation is based on the model Peter Lynch Fair Value. With the current market price of 0.05 EUR, the upside of NOXXON Pharma NV is -3,316.00%.
Based on its market price of 0.05 EUR and our intrinsic valuation, NOXXON Pharma NV (ALNOX.PA) is overvalued by 3,316.00%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -1.61 - -1.61 | -1.61 | -3,316.00% |
| P/E | (2.06) - (4.22) | (3.43) | -6964.7% |
| DDM - Stable | (1.75) - (7.19) | (4.47) | -9038.3% |
| DDM - Multi | (0.90) - (2.97) | (1.39) | -2880.7% |
| Market Cap (mil) | 6.81 |
| Beta | 1.83 |
| Outstanding shares (mil) | 136.11 |
| Enterprise Value (mil) | -2.63 |
| Market risk premium | 5.23% |
| Cost of Equity | 8.80% |
| Cost of Debt | 5.00% |
| WACC | 8.79% |